What is GI INNOVATION's contact information?

GI INNOVATION's contact information: ir@gi-innovation.com, +8224042003.

How many employees does GI INNOVATION have?

GI INNOVATION has 34 employees.

What tech stack does GI INNOVATION use?

Some of the popular technologies that GI INNOVATION uses are: Naver Analytics, Cloudflare, CDNJS, Unpkg, jQuery CDN, jsDelivr, Microsoft 365.

What are GI INNOVATION's office addresses?

GI INNOVATION has 4 known office addresses: 서울특별시 송파구 송파대로 167, 에이동 1116호 (문정동, 문정역테라타워) 송파구 송파대로 167 문정역테라타워 A동 1116호 서울, Seoul 05855, KR 송파구 송파대로 167 문정역테라타워 A동 1114-1115호 서울, Seoul 05855, KR 화촌면 답연밭길 101 서울대학교시스템면역의학연구소 A동 1C08 홍천군, 강원도 25159, KR.

What is GI INNOVATION's estimated annual revenue?

GI INNOVATION's revenue is $3,653,000

What is GI INNOVATION's open headcount?

GI INNOVATION has no job postings yet.

What is the number of ad campaigns for GI INNOVATION?

GI INNOVATION has no advertisements yet.

What is the number of recent news articles about GI INNOVATION?

GI INNOVATION has 5 news articles.

GI INNOVATION - Pubrio Company Profile & Intent

Q: What industry does GI INNOVATION belong to?

GI INNOVATION is in the industry of: Research, Pharmaceuticals, Biotechnology, Health, Wellness And Fitness, Biotechnology Research.

GI INNOVATION

South Korea · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Health, Wellness And Fitness

Biotechnology Research

GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.

Company Insights

digitaltoday.co.kr · sells_assets_to · 16 hours ago

Open news

GI Innovation Major Shareholder Reduces Stake

GI Innovation's major shareholder Jang Myung Ho reduced holdings by 13.337 million shares, decreasing stake from 26.49% to 6.63%. The reduction includes changes in special relationships and stock-secured loan arrangements.

prnasia.com · partners_with · 2 weeks ago

Open news

GI Innovation partners with J&J for cancer therapy trial

GI Innovation and Johnson & Johnson collaborate on phase 1b trial for prostate cancer combination therapy, combining GI-102 with pasritamig in Korea and US.

kipost.net · recognized_as · 2025-05-13

Open news

GI Innovation advances in XPRIZE Healthspan competition

GI Innovation and GI Biome reach XPRIZE Healthspan semi-finals, proposing anti-aging therapy combining GI-102 and GIB-7. They're among 40 semi-finalists from 600 teams globally.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 5 of 5

Frequently Asked Questions Regarding GI INNOVATION

Company Overview

2017

Founded

Biotechnology Research

Industry

South Korea

Location

2,756,316

Ranking

34 employees

Size

Similar Companies

Get full access to view complete information